Select Publications
Journal articles
2008, 'Venous thromboembolism - a major health and financial burden: how can we do better to prevent this disease?', Medical Journal of Australia, 189, pp. 134 - 135
,2007, 'Analysis of the signals and mechanisms mediating nuclear trafficking of GATA-4: Loss of DNA binding is associated with localization in intranuclear speckles', The Journal of Biological Chemistry, 282, pp. 24915 - 24927, http://dx.doi.org/10.1074/jbc.M701789200
,2007, 'Effects of notoginosides on proliferation and upregulation of GR nuclear transcription factor in hematopoietic cells', ACTA Pharmacologica Sinica, 28, pp. 703 - 711
,2007, 'Identification of a monopartite sequence in PU.1 essential for nuclear import, DNA-binding and transcription of myeloid-specific genes', Journal of Cellular Biochemistry, 101, pp. 1456 - 1474
,2007, 'Management of thromboembolism in hematologic malignancies', Seminars in Thrombosis and Hemostasis, 33, pp. 435 - 447
,2007, 'NF-E2 mediated enhancement of megakaryocytic differentation and platelet production in vitro and in vivo', Experimental Hematology, 35, pp. 35 - 36
,2007, 'Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism', Chest, 132, pp. 936 - 945
,2006, 'Human and mouse mast cells use the Tetraspanin CD9 as an alternate Interleukin 16 receptor', Blood, 107, pp. 135 - 142
,2006, 'Proplatelet production from haematopoeitic stem cells enhanced by NF-E2 overexpression', Cytotherapy, 8
,2006, 'Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors', Journal of Thrombosis and Haemostasis, 4, pp. 678 - 679
,2005, 'Factors at Admission That Are Predictive of Increased In-Hospital Bleeding in Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE).', Blood, 106, pp. 264 - 264, http://dx.doi.org/10.1182/blood.v106.11.264.264
,2005, 'Influence of Perceived Risk Factors for Bleeding on Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients: Findings from IMPROVE.', Blood, 106, pp. 917 - 917, http://dx.doi.org/10.1182/blood.v106.11.917.917
,2005, 'AML1-FOG2 fusion protein myelodyspasia', Blood, 105, pp. 4523 - 4526
,2005, 'Autoimmune thrombocytopenia', Journal of Thrombosis and Haemostasis, 3, pp. 1763 - 1772
,2005, 'Effect of fondaparinux on platelet activaton in the presence of heparin-dependent antibodies: a blinded comparative multicentre study with unfjractionated heparin', Blood, 105, pp. 139 - 144
,2005, 'Identification of nuclear import and export signals within Fli: Roles of the nuclear Import signals in Fli-1-dependant activation of megakaryocyte-specific promoters.', Molecular and Cellular Biology, 25, pp. 3087 - 3108, http://dx.doi.org/10.1128/MCB.25.8.3087-3108.2005
,2005, 'Once-Daily Enoxaparin in The Outpatient Setting Versus Unfractioned Heparin in Hospital for the Treatment of Symptomatic Deep-Vein Thrombosis', Journal of Thrombosis and Thrombolysis, 19, pp. 173 - 181
,2004, 'AML1-FOG2 Fusion Protein in Myelodysplasia.', Blood, 104, pp. 2900 - 2900, http://dx.doi.org/10.1182/blood.v104.11.2900.2900
,2004, 'The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE): Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients.', Blood, 104, pp. 1762 - 1762, http://dx.doi.org/10.1182/blood.v104.11.1762.1762
,2004, 'A Multinational Comparison of Prophylaxis Practices for Venous Thromboembolism During Medical Intensive Care: Findings from IMPROVE', CHEST Journal, 126, pp. 784s-1-784s-2, http://dx.doi.org/10.1378/chest.126.4_meetingabstracts.784s
,2004, 'Does Obesity Influence Physician Practices in Provision of Prophylaxis for Venous Thromboembolism? Lessons from IMPROVE', CHEST Journal, 126, pp. 783sc-1-783sc-2, http://dx.doi.org/10.1378/chest.126.4_meetingabstracts.783s-c
,2004, 'Erratum: Protein-protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA binding (Molecular and Cellular Biology (2003) 23, 10 (3427-3441))', Molecular and Cellular Biology, 24, pp. 5088, http://dx.doi.org/10.1128/MCB.24.11.5088.2004
,2004, 'Heparin-induced thrombocytopenia', Expert Review of Cardiovascular Therapy, 2, pp. 547 - 559, http://www.sciencedirect.com/science/article/B6WVB-4CTDFW1-1VR/2/6cf00162d879fc3c5c98a49f3a89a1f6
,2003, 'Heparin-induced thrombocytopenia', Journal of Thrombosis and Haemostasis, 1, pp. 1471 - 1478, http://dx.doi.org/10.1046/j.1538-7836.2003.00270.x
,2003, 'Analysis of gene regulation by Fli-1 during megakaryopoeisis', Blood, 102, pp. 158B - 158B
,2003, 'Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice', Pathology, 35, pp. 458 - 458, http://dx.doi.org/10.1016/s0031-3025(16)34302-1
,2003, 'Drug-induced thrombocytopenia: Localization of the binding site of GPlX-specific quinine-dependent antibodies', Blood, 102, pp. 1670 - 1676
,2003, 'Effect of fondaparinux on platelet activation in the presence ofheparin-dependent anti-platelet antibodies. A blinded comparativemulticenter study with unfractionated heparin', Blood, 102, pp. 319A - 319A
,2003, 'Immobility and advanced age: Critical factors contributing to theoverall risk of venous thromboembolism in medical patients', Blood, 102, pp. 56A - 57A
,2003, 'Protein-protein interaction between Fli-1 and GATA 1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA binding', Molecular and Cellular Biology, 23, pp. 3427 - 3441, http://dx.doi.org/10.1128/MCB.23.10.3427-3441.2003
,2003, 'Thrombospondin-1 inhibits invitro megakaryocytopoiesis via CD36', Thrombosis Research, 109, pp. 47 - 54
,2002, 'Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia', Annals of Oncology, 13, pp. 770 - 776, http://dx.doi.org/10.1093/annonc/mdf117
,2002, 'Anti-Mta associated with three cases of hemolytic disease of the newborn', Immunohematology, 18, pp. 37 - 39
,2002, 'Cloning and analysis of the thrombopoietin-induced MEgakaryocyte-specific Glycoprotein VI Promoter and Its Regulation by GATA-1, Fli-1, and Sp1', The Journal of Biological Chemistry, 277, pp. 48333 - 48341
,2002, 'Site-directed mutagenesis of platelet glycoprotein Ib-alpha demonstrating residues involved in the sulfation of tyrosines 276, 278 and 279', Blood, 99, pp. 4422 - 4427
,2001, 'The protein-protein interaction between FLI-1 and GATA-1 is crucial for expression of the megakaryocyte-specific gene Glycoprotein IX.', BLOOD, 98, pp. 286A - 286A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000172134101211&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2001, 'Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: A clinical outcome study', Thrombosis and Haemostasis, 86, pp. 1170 - 1175, http://dx.doi.org/10.1055/s-0037-1616046
,2001, 'Six weeks of oral anticoagulation is sufficient for isolated calf deep vein thrombosis', Evidence-based Healthcare, 5, pp. 136 - 137, http://dx.doi.org/10.1054/ebhc.2001.0445
,2001, 'Heparin-induced thrombocytopenia and thrombosis syndrome: in vivo cross-reactivity with danaparoid and successful treatment with r-hirudin', British Journal of Haematology, 114, pp. 394 - 396
,2001, 'Identification and characterisation of a platelet GPIb/V/IX-like complex on human breast cancers: Implications for the metastatic process', Japanese Journal of Cancer Research, 92, pp. 1082 - 1092
,2001, 'Inducible expression of the megakarocyte-specific gene glycoprotein IX is mediated through an ets binding site and involves upstream activation of extracellular signal-regulated kinase', Cell Growth and Differentiation, 12, pp. 435 - 445
,2001, 'Management of deep vein thrombosis', Australian Family Physician, pp. 235 - 240
,2001, 'Phenotype changes resulting in high-affinity binding of von Willebrand factor to recombinant glycoprotein Ib-IX: analysis of the platelet-type von Willebrand disease mutations', Blood, pp. 1812 - 1818
,2001, 'Platelet-derived growth factor enhances granulopoiesis via bone marrow stromal cells', International Journal of Hematology, pp. 327 - 334
,2000, 'Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity: A phase II evaluation', Circulation, 102, pp. 2726 - 2731, http://dx.doi.org/10.1161/01.CIR.102.22.2726
,2000, 'Inducible expression of GPIX by PMA and TPO in megakaryocytic cells requires an intact Ets site and upstream activation of ERK.', BLOOD, 96, pp. 672A - 672A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000165256102891&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2000, 'Phenotype changes resulting in high-affinity binding of vWF to recombinant GPIb: Analysis of platelet-type von Willebrand disease mutations.', BLOOD, 96, pp. 624A - +, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000165256102683&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2000, 'Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4–heparin antibodies to platelets and the resultant platelet activation', Blood, 96, pp. 182 - 187, http://dx.doi.org/10.1182/blood.v96.1.182
,2000, 'A comparison of polymorphism in the 3`-untranslated region of the prothrombin gene between Chinese and Caucasians', British Journal of Haematology, 111, pp. 1253 - 1255
,2000, 'Advances in the diagnosis of idiopathic thrombocytopenic purpura', Seminars in Hematology, pp. 249 - 260
,